Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

NovoSeven RT

Drug Hemophilia

NDC 0169-7010-01

Open in the dashboard

General payments

$270,832

390 payments

Research payments

$0

0 payments

Through program year 2019, $270,832 in general payments and $0 in research payments were reported against NovoSeven RT (Hemophilia).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $270,832 390

Breakdown

Who paid General payments · program year 2019
  1. Novo Nordisk Inc $226,099 374 payments
  2. Novo Nordisk Health Care AG $26,204 11 payments
  3. Novo Nordisk AS $18,529 5 payments
Top recipients General payments · program year 2019
  1. Miguel Escobar Hematology · Houston, TX $31,250 12% · 8 payments
  2. Craig Kessler Hematology & Oncology · Washington, DC $28,354 10% · 9 payments
  3. Sandeep Rajan Hematology & Oncology · Nashville, TN $25,940 10% · 14 payments
  4. Leslie Soto Velez Pediatrics · San Juan, PR $25,039 9% · 10 payments
  5. Thomas Abshire Pediatric Hematology-Oncology · Milwaukee, WI $21,817 8% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatric Hematology-Oncology Pediatrics $83,769 31% · 67 practitioners
  2. Hematology Internal Medicine $67,461 25% · 6 practitioners
  3. Hematology & Oncology Internal Medicine $62,316 23% · 43 practitioners
  4. Pediatrics $37,643 14% · 13 practitioners
  5. Blood Banking & Transfusion Medicine Pathology $6,490 2% · 1 practitioner

The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. District of Columbia $43,004 16% · 4 recipients
  2. Texas $31,409 12% · 12 recipients
  3. Tennessee $27,869 10% · 16 recipients
  4. Puerto Rico $25,775 10% · 7 recipients
  5. Wisconsin $21,817 8% · 1 recipient

The top 5 of 29 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

390 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record